Ibucalm (Ibuprofen)

Ibuprofen, the active ingredient in Ibucalm, blocks the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for prostaglandin production. By lowering prostaglandin levels, the drug reduces the sensitisation of pain receptors, diminishes inflammatory swelling, and helps normalise body temperature when fever is present.

The specific dose and frequency of Ibucalm are determined by the prescribing healthcare professional based on the severity of symptoms, the size of the treatment area, and individual patient factors. Patients should follow the prescriber's instructions and the product label for proper application.

Ibucalm should be used with caution during pregnancy, especially in the third trimester, and only if the potential benefit outweighs the risk. Limited data are available for breastfeeding; therefore, a healthcare provider should be consulted before use to assess safety for both mother and infant.

To order Ibucalm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ibucalm contains ibuprofen, a well‑studied NSAID, and offers analgesic and anti‑inflammatory effects comparable to other topical NSAIDs such as diclofenac gel. Its transdermal delivery provides localized action with minimal systemic exposure, making it suitable for patients who prefer a non‑oral option while still achieving effective pain relief.

Ibucalm should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed when not in use and out of reach of children.

Ibucalm is applied topically to clean, dry skin over the painful or inflamed area. A thin layer is spread gently and rubbed in until absorbed. The exact amount and frequency depend on the prescriber's guidance, typically not exceeding the recommended number of applications per day.

Serious risks, though rare with topical use, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, or toxic epidermal necrolysis. Systemic effects like gastrointestinal bleeding or renal impairment can occur if large amounts are absorbed, especially in patients with pre‑existing conditions.

Individuals with known hypersensitivity to ibuprofen, other NSAIDs, or any component of the formulation should avoid Ibucalm. It is also contraindicated in patients with active gastrointestinal ulcers, severe heart failure, or uncontrolled hypertension without medical advice.